[3]
Pfyffer, G. E. Mycobacterium: General characteristics, laboratory detection, and staining procedures. Man. Clin. Microbiol., 2015, 536-569.
[4]
Jnawali, H.N.; Ryoo, S. First- and second-line drugs and drug resistance. Tuberc.: Curr. Issues Diagn. Manage., 2013, 20, 163-180.
[17]
Peter, J.G.; Haripesad, A.; Mottay, L.; Kraus, S.; Meldau, R.; Dheda, K. The clinical utility of urine lipoarabinomannan and the novel point-of-care lateral flow strip test (Determine® TB) for the diagnosis of tuberculosis in hospitalised patients with HIV-related advanced immunosuppression. Am. J. Respir. Crit. Care Med., 2011, 183, A5313.
[31]
Crofton, S.J.; Chaulet, P.; Maher, D.; Grosset, J.; Harris, W.; Horne, N.; Iseman, M.; Watt, B. Guidelines for the management of drug-resistant tuberculosis; World Health Organization, 1997.
[32]
Organization, W.H. Guidelines for the programmatic management of drug-resistant tuberculosis: Emergency update 2008; World Health Organization, 2008.
[33]
Organization, W.H. Rapid communication: Key changes to treatment of multidrug-and rifampicin-resistant tuberculosis (MDR/RR-TB); World Health Organization, 2018.
[37]
Palleapati, K.; Kancharlapalli, V.R.; Shaik, A.B. Synthesis, characterization and anti-tubercular evaluation of some new isoxazole appended 1-carboxamido-4, 5-dihydro-1H-pyrazoles. J. Res. Pharm., 2019, 23(2), 156-163.
[49]
Sharabu, R.; Pappula, N. Synthesis, characterization, anti-mycobacterial evaluation and in-silico molecular docking of novel isoxazole clubbed pyrimidine derivatives. J. Pharm. Res. Int., 2021, 33(26B), 69-79.
[52]
Płoszaj, P.; Junka, A.; Szponar, B.; Mączyński, M.; Ryng, S.; Bartoszewicz, M.; Piwowar, A. Insights into mycobacterial activity and cytotoxicity of substitued isoxazole-4-carbohydrazide derivatives. Acta Pol. Pharm., 2018, 75(3), 637-647.
[57]
Solankee, A.; Tailor, R.; Kapadia, K. In vitro antimycobacterial and antimicrobial activity of some new pyrazoline, isoxazole and benzodiazepine derivatives containing 1, 3, 5-triazine nucleus via chalcone series. Indian J. Chem. Sect. B: Org. Chem. Incl. Med. Chem., 2016, 55, 1277-1287.
[64]
Rajurkar, V.; Patil, R.; Bhanojirao, M.; Pattan, S. Synthesis, characterization and antimicrobial, antifungal and anti-tubercular activity of some 3, 5-substituted isoxazoles, 4-[(3, 5-substituted, 1H-pyrazol-1-yl) carbonyl] pyridines and 4, 6-substituted pyrimidin-2-amines. Int. J. Adv. In Phar. Biol. Chem., 2012, 1(1), 1-6.
[71]
Kachhadia, V.; Patel, M.; Joshi, H. Synthesis of isoxazoles and cyanopyridines bearing benzo (b) thiophene nucleus as potential anti-tubercular and antimicrobial agents. J. Sci. Islamic Repub. Iran, 2004, 15(1), 47-51.
[72]
Doshi, R.; Kagthara, P.; Parekh, H. Synthesis and biological evaluation of some novel isoxazoles and cyanopyridines, a new class of potential anti-tubercular agents. Indian J. Chem. Sect. B: Org. Chem. Incl. Med. Chem, 1999, 38, 348-352.